Pure Bioscience secures up to $3M in convertible notes; initial $500k from director Tom Y. Lee

PURE BIOSCIENCE, INC.

Initial tranche of $500,000 convertible promissory note placed with director Tom Y. Lee (affiliates).
Notes bear 7.88% annual interest, mature 3 years; convertible into common at VWAP floor $0.095, cap $0.175.
Company may conduct subsequent closings up to $3.0 million aggregate principal through July 31, 2025.
Conversion triggers include automatic conversion one year after issuance at option of majority holders, and upon corporate transactions.
Offering is exempt from registration under Section 4(a)(2) of the Securities Act.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.